GeneDx Holdings Corp. Class A Common Stock (WGS)
NASDAQ
63.61
-6.61 (-9.41%)
Delayed Data
Oct 16, 2026, 01:30 PM
Day's Range
62.4970.20
52 wk Range
32.21170.87
Financial Statements - WGS - GeneDx Holdings Corp. Class A Common Stock
Revenue
427.53M▲ 40.0%
Net Income
-21.02M▲ 59.8%Net Margin -4.9%
EBITDA
13.35M▲ 10.2%
Free Cash Flow
14.26M▲ 142.0%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 427.53M | 305.45M | 202.56M | 234.69M | 212.19M | 179.32M |
| Cost of Goods | 129.36M | 111.05M | 112.56M | 261.44M | 228.79M | 175.29M |
| Gross Profit | 298.17M | 194.39M | 90M | -26.75M | -16.60M | 4.02M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -13.07M | -23.21M | -170.19M | -457.50M | -446.14M | -241.99M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | -5.52M | -26.38M | -7.61M | -139.85M | 203.51M | 2.62M |
| Pre Tax Income | -21.13M | -52.62M | -176.69M | -598.03M | -245.39M | -241.34M |
| Income Tax | -116K | -343K | -926K | -49.05M | 0 | 0 |
| Net Income | -21.02M | -52.28M | -175.76M | -548.98M | -245.39M | -241.34M |
| EPS Basic | -0.73 | -1.94 | -7.23 | -53.79 | -74.91 | -33.157945 |
| EPS Diluted | -0.73 | -1.94 | -7.23 | -53.79 | -74.91 | -33.157945 |
| Basic Shares Outstanding | 28.64M | 26.89M | 24.31M | 10.23M | 3.27M | 7.27M |
| Diluted Shares Outstanding | 28.64M | 26.89M | 24.31M | 10.23M | 3.27M | 7.27M |
| Ebit | -13.07M | -23.21M | -170.19M | -457.50M | -242.55M | -238.86M |
| Ebitda | 13.35M | 12.11M | -127.22M | -258.28M | -419.14M | -227.13M |
| Net Income Continuous Operations | -21.02M | -52.28M | -175.76M | -548.98M | -245.39M | -241.34M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
